These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 32936421

  • 41. Synergistic effect of honokiol and 5-fluorouracil on apoptosis of oral squamous cell carcinoma cells.
    Ji N, Jiang L, Deng P, Xu H, Chen F, Liu J, Li J, Liao G, Zeng X, Lin Y, Feng M, Li L, Chen Q.
    J Oral Pathol Med; 2017 Mar; 46(3):201-207. PubMed ID: 27465776
    [Abstract] [Full Text] [Related]

  • 42. Magnolol Inhibits the Growth of Non-Small Cell Lung Cancer via Inhibiting Microtubule Polymerization.
    Shen J, Ma H, Zhang T, Liu H, Yu L, Li G, Li H, Hu M.
    Cell Physiol Biochem; 2017 Mar; 42(5):1789-1801. PubMed ID: 28746938
    [Abstract] [Full Text] [Related]

  • 43. Honokiol confers immunogenicity by dictating calreticulin exposure, activating ER stress and inhibiting epithelial-to-mesenchymal transition.
    Liu SH, Lee WJ, Lai DW, Wu SM, Liu CY, Tien HR, Chiu CS, Peng YC, Jan YJ, Chao TH, Pan HC, Sheu ML.
    Mol Oncol; 2015 Apr; 9(4):834-49. PubMed ID: 25619450
    [Abstract] [Full Text] [Related]

  • 44. Autophagosome accumulation-mediated ATP energy deprivation induced by penfluridol triggers nonapoptotic cell death of lung cancer via activating unfolded protein response.
    Hung WY, Chang JH, Cheng Y, Cheng GZ, Huang HC, Hsiao M, Chung CL, Lee WJ, Chien MH.
    Cell Death Dis; 2019 Jul 15; 10(8):538. PubMed ID: 31308361
    [Abstract] [Full Text] [Related]

  • 45. β-Apopicropodophyllin functions as a radiosensitizer targeting ER stress in non-small cell lung cancer.
    Kim JY, Cho JH, Kim EM, Shin HJ, Hwang SG, Song JY, Um HD, Park JK.
    Biomed Pharmacother; 2019 May 15; 113():108769. PubMed ID: 30870718
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Honokiol inhibits epidermal growth factor receptor signaling and enhances the antitumor effects of epidermal growth factor receptor inhibitors.
    Leeman-Neill RJ, Cai Q, Joyce SC, Thomas SM, Bhola NE, Neill DB, Arbiser JL, Grandis JR.
    Clin Cancer Res; 2010 May 01; 16(9):2571-9. PubMed ID: 20388852
    [Abstract] [Full Text] [Related]

  • 50. Honokiol regulates endoplasmic reticulum stress by promoting the activation of the sirtuin 1-mediated protein kinase B pathway and ameliorates high glucose/high fat-induced dysfunction in human umbilical vein endothelial cells.
    Ye H, Meng Y.
    Endocr J; 2021 Aug 28; 68(8):981-992. PubMed ID: 33952780
    [Abstract] [Full Text] [Related]

  • 51. Honokiol induces autophagy of neuroblastoma cells through activating the PI3K/Akt/mTOR and endoplasmic reticular stress/ERK1/2 signaling pathways and suppressing cell migration.
    Yeh PS, Wang W, Chang YA, Lin CJ, Wang JJ, Chen RM.
    Cancer Lett; 2016 Jan 01; 370(1):66-77. PubMed ID: 26454217
    [Abstract] [Full Text] [Related]

  • 52. Concurrently suppressing multidrug resistance and metastasis of breast cancer by co-delivery of paclitaxel and honokiol with pH-sensitive polymeric micelles.
    Wang Z, Li X, Wang D, Zou Y, Qu X, He C, Deng Y, Jin Y, Zhou Y, Zhou Y, Liu Y.
    Acta Biomater; 2017 Oct 15; 62():144-156. PubMed ID: 28842335
    [Abstract] [Full Text] [Related]

  • 53. 6-Shogaol induces caspase-independent paraptosis in cancer cells via proteasomal inhibition.
    Nedungadi D, Binoy A, Pandurangan N, Pal S, Nair BG, Mishra N.
    Exp Cell Res; 2018 Mar 15; 364(2):243-251. PubMed ID: 29462602
    [Abstract] [Full Text] [Related]

  • 54. Emodin induces apoptosis of lung cancer cells through ER stress and the TRIB3/NF-κB pathway.
    Su J, Yan Y, Qu J, Xue X, Liu Z, Cai H.
    Oncol Rep; 2017 Mar 15; 37(3):1565-1572. PubMed ID: 28184934
    [Abstract] [Full Text] [Related]

  • 55. Honokiol inhibits lung tumorigenesis through inhibition of mitochondrial function.
    Pan J, Zhang Q, Liu Q, Komas SM, Kalyanaraman B, Lubet RA, Wang Y, You M.
    Cancer Prev Res (Phila); 2014 Nov 15; 7(11):1149-59. PubMed ID: 25245764
    [Abstract] [Full Text] [Related]

  • 56. Honokiol induces apoptosis of lung squamous cell carcinoma by targeting FGF2-FGFR1 autocrine loop.
    Cen M, Yao Y, Cui L, Yang G, Lu G, Fang L, Bao Z, Zhou J.
    Cancer Med; 2018 Dec 15; 7(12):6205-6218. PubMed ID: 30515999
    [Abstract] [Full Text] [Related]

  • 57. Synergistic antitumor effects of liposomal honokiol combined with adriamycin in breast cancer models.
    Hou W, Chen L, Yang G, Zhou H, Jiang Q, Zhong Z, Hu J, Chen X, Wang X, Yuan Y, Tang M, Wen J, Wei Y.
    Phytother Res; 2008 Aug 15; 22(8):1125-32. PubMed ID: 18570244
    [Abstract] [Full Text] [Related]

  • 58. Honokiol activates AMP-activated protein kinase in breast cancer cells via an LKB1-dependent pathway and inhibits breast carcinogenesis.
    Nagalingam A, Arbiser JL, Bonner MY, Saxena NK, Sharma D.
    Breast Cancer Res; 2012 Feb 21; 14(1):R35. PubMed ID: 22353783
    [Abstract] [Full Text] [Related]

  • 59. Radiosensitization of NSCLC cells to X-rays and carbon ions by the CHK1/CHK2 inhibitor AZD7762, Honokiol and Tunicamycin.
    Liu B, Chen W, Li H, Li F, Jin X, Li Q.
    Radiat Environ Biophys; 2020 Nov 21; 59(4):723-732. PubMed ID: 32857208
    [Abstract] [Full Text] [Related]

  • 60. Multifunctional effects of honokiol as an anti-inflammatory and anti-cancer drug in human oral squamous cancer cells and xenograft.
    Cho JH, Jeon YJ, Park SM, Shin JC, Lee TH, Jung S, Park H, Ryu J, Chen H, Dong Z, Shim JH, Chae JI.
    Biomaterials; 2015 Nov 21; 53():274-84. PubMed ID: 25890726
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.